The content on this website is intended solely for veterinarians and other animal health professionals.
By using this website, you confirm that the above applies to you.
Intervacc AB and the Swedish University of Agricultural Sciences, SLU, sign a multi-year contract for the development of innovative animal health vaccines
Intervacc AB and the Swedish University of Agricultural Sciences, SLU, have signed a multi-year contract for the development of a new generation of animal health vaccines using recombinant proteins. The contract is a continuation and expansion of the very successful...Update of contact information for Certified Adviser for previous Press Release – Large-scale manufacturing process for Strangvac now secured
Update of previous Press Release distributed April 1, 2019: Contact information for Certified Adviser added. Otherwise no changes. The biotechnology company Intervacc has together with 3P Biopharmaceuticals, the contracted manufacturer of Strangvac, secured...Large-scale manufacturing process for Strangvac now secured
The biotechnology company Intervacc has together with 3P Biopharmaceuticals, the contracted manufacturer of Strangvac, secured large-scale production of the vaccine against equine strangles. The technology transfer of manufacturing and the verification of...New CEO appointed for Intervacc – a innovative and expanding vaccine company
Intervacc, a Swedish innovative vaccine company listed on Nasdaq First North, has appointed Andreas Andersson as CEO. The Company thus gains a valuable addition to lead the expansion and strategic development on the growth journey for a new generation of animal health...Nyhetstjänster
